Literature DB >> 15388674

Historical perspectives in gonadotrophin therapy.

Bruno Lunenfeld1.   

Abstract

The 20th century witnessed the steady development of knowledge about the reproductive process in animals and humans. These advances led to the identification of higher centres governing the dynamics of ovarian function and to the discovery of gonadotrophic hormones. As the mechanisms of action of these hormones became increasingly understood, they began to be used in the management of infertility during the early 1930s. Hormone extracts were originally prepared from animal pituitaries and pregnant mare serum, as well as from human pituitaries, placenta and urine, with pregnancies reported following their use in the late 1930s. This review traces the constant quest to reduce risks and improve safety and efficacy of hormone preparations for patients. It describes the complex path and perils leading to the pure hormone preparations that are available today, concluding with an optimistic glimpse towards the future. Small molecules that are orally active and specific are currently being investigated, some with the capacity to bypass many parts of the receptor conformation. Here lies the immediate future of this field, utilizing low-cost, small, defined molecules to stimulate follicle growth, ovulation and corpus luteum formation. Perhaps one day the classical gonadotrophins will no longer be required in clinical treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15388674     DOI: 10.1093/humupd/dmh044

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  41 in total

Review 1.  Molecular pharmacology of gonadotropins.

Authors:  Robert K Campbell
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

Review 2.  Pituitary-gonadal axis: historical notes.

Authors:  J Lindholm; E Husted Nielsen
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 3.  The mammalian ovary from genesis to revelation.

Authors:  Mark A Edson; Ankur K Nagaraja; Martin M Matzuk
Journal:  Endocr Rev       Date:  2009-09-23       Impact factor: 19.871

Review 4.  Novel pathways in gonadotropin receptor signaling and biased agonism.

Authors:  Alfredo Ulloa-Aguirre; Pascale Crépieux; Anne Poupon; Marie-Christine Maurel; Eric Reiter
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

5.  The multiple birth epidemic: revisited.

Authors:  Sarit Avraham; Daniel S Seidman
Journal:  J Obstet Gynaecol India       Date:  2012-08

6.  A profile of Bruno Lunenfeld, MD, FRCOG, FACOG (hon).

Authors:  Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2018-09       Impact factor: 8.661

7.  Recombinant follitropin alfa/lutropin alfa in fertility treatment.

Authors:  Ahmed Gibreel; Siladitya Bhattacharya
Journal:  Biologics       Date:  2010-02-04

8.  Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study.

Authors:  J Thomas Welcker; Frank Nawroth; Wilma Bilger
Journal:  Reprod Biol Endocrinol       Date:  2010-09-15       Impact factor: 5.211

9.  A comparison of menotropin, highly-purified menotropin and follitropin alfa in cycles of intracytoplasmic sperm injection.

Authors:  Sandro C Esteves; Joan C Schertz; Sidney Verza; Danielle T Schneider; Silval F C Zabaglia
Journal:  Reprod Biol Endocrinol       Date:  2009-10-14       Impact factor: 5.211

10.  Administration of follitropin alfa and lutropin alfa combined in a single injection: a feasibility assessment.

Authors:  Rita Agostinetto
Journal:  Reprod Biol Endocrinol       Date:  2009-05-18       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.